Body mass index and risk of mortality in patients undergoing bariatric surgery
- PMID: 36156736
- DOI: 10.1007/s00464-022-09651-7
Body mass index and risk of mortality in patients undergoing bariatric surgery
Abstract
Background: Prior literature has demonstrated that bariatric surgery is a safe approach for patients with morbid obesity. However, the relationship between body mass index (BMI) and risk of mortality in these patients has not been fully elucidated. Primary objective of this study was to evaluate the relationship between BMI and risk of mortality using data obtained from a national database, with a special focus on patients with BMI ≥ 70.0 kg/m2.
Methods: A retrospective cohort study of patients with morbid obesity (BMI ≥ 40 kg/m2) undergoing first-time bariatric surgery between 2015 and 2018 was performed using data from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. Primary outcome was intra-operative death or death within 30 days post-operatively. Patients were categorized into quartiles according to BMI. Multivariable analysis was performed to evaluate the association of BMI with risk of mortality. Relative risk (RR) and 95% confidence interval (CI) are provided as measures of strength of association and precision, respectively.
Results: A total of 463, 436 patients were included with a 30-day mortality rate of 0.11%. Mean BMI (SD) was 48.2 (7.3) kg/m2; 1.5% of patients had BMI ≥ 70.0 kg/m2. On multivariable analysis, highest quartile patients had a significantly higher risk of mortality than lowest quartile patients. For patients with BMI ≥ 70.0 kg/m2, the risk of mortality was more pronounced with an eightfold increase compared to the lowest quartile. In patients with BMI ≥ 70.0 kg/m2, although sleeve gastrectomy (SG) was the most common procedure, the risk of mortality was significantly higher in patients undergoing Roux-en-Y gastric bypass (RYGB).
Conclusions: BMI is associated with increased risk of 30-day mortality. The effect of BMI is more pronounced in patients with BMI ≥ 70.0 kg/m2. In these patients, RYGB is associated with increased risk of mortality compared to SG.
Keywords: Body mass index; Morbid obesity; Post-operative mortality; Roux-en-Y gastric bypass; Sleeve gastrectomy.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Thirty-day outcomes of sleeve gastrectomy versus Roux-en-Y gastric bypass: first report based on Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database.Surg Obes Relat Dis. 2018 May;14(5):545-551. doi: 10.1016/j.soard.2018.01.011. Epub 2018 Jan 13. Surg Obes Relat Dis. 2018. PMID: 29551470
-
Bariatric surgery in the elderly: outcomes analysis of patients over 70 using the ACS-NSQIP database.Surg Obes Relat Dis. 2019 Nov;15(11):1923-1932. doi: 10.1016/j.soard.2019.08.011. Epub 2019 Aug 23. Surg Obes Relat Dis. 2019. PMID: 31611184
-
Ten year comparative analysis of sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch in patients with BMI ≥ 50 kg/m2.Surg Endosc. 2022 Jul;36(7):4946-4955. doi: 10.1007/s00464-021-08850-y. Epub 2021 Nov 3. Surg Endosc. 2022. PMID: 34731300
-
Outcomes of same-day discharge sleeve gastrectomy and Roux-en-Y gastric bypass: a systematic review and meta-analysis.Surg Obes Relat Dis. 2023 Mar;19(3):238-249. doi: 10.1016/j.soard.2022.09.004. Epub 2022 Sep 11. Surg Obes Relat Dis. 2023. PMID: 36209031
-
Impact of Body Mass Index on All-Cause Mortality in Adults: A Systematic Review and Meta-Analysis.J Clin Med. 2024 Apr 16;13(8):2305. doi: 10.3390/jcm13082305. J Clin Med. 2024. PMID: 38673577 Free PMC article. Review.
Cited by
-
Multi-modal neo-adjuvant anti-obesity medications may be more effective than medically supervised weight loss or GLP-1 therapy alone in preparing BMI≥70 patients for metabolic surgery.Int J Obes (Lond). 2025 Aug;49(8):1516-1522. doi: 10.1038/s41366-025-01798-2. Epub 2025 Jun 2. Int J Obes (Lond). 2025. PMID: 40456879 Free PMC article.
-
A Ring-Augmented Roux-en-Y Gastric Bypass with MiniMizer Ring is Effective and Safe in Patients with a BMI >50 kg/m2.Obes Surg. 2025 Aug;35(8):3013-3019. doi: 10.1007/s11695-025-07988-1. Epub 2025 Jun 26. Obes Surg. 2025. PMID: 40569360 Free PMC article.
-
Investigation of homocysteine level after bariatric metabolic surgery, effect on vitamin B12 and folate levels.BMC Endocr Disord. 2024 Nov 6;24(1):237. doi: 10.1186/s12902-024-01773-4. BMC Endocr Disord. 2024. PMID: 39501209 Free PMC article.
References
-
- Medical Advisory Secretariat (2009) Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis. Ont Health Technol Assess Ser 9:1–23 - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials